Bharglob 16.5% Injection is a medication aimed at enhancing the body's natural immune system to reduce the likelihood of infections, especially in individuals with weakened immune systems. This injection is derived from healthy human blood that contains a high concentration of defensive substances known as antibodies, which play a crucial role in combatting infections.

Studies have demonstrated the efficacy of Bharglob 16.5% Injection in preventing infections in bone marrow transplant patients over 20 years old within the initial 100 days post-transplant. It is particularly beneficial for individuals with severely impaired antibody-forming capacity, putting them at a higher risk of infections. By providing the body with antibodies it may not produce independently, this injection enables individuals to better fight off infections. Both children and adults can benefit from this therapy, which is administered via injection under the supervision of a healthcare professional.

While Bharglob 16.5% Injection offers significant advantages, it may also lead to side effects such as injection site reactions like swelling, redness, pain, and itching, as well as flushing or a sensation of warmth in certain areas. Any discomfort or unusual symptoms should be reported to the doctor for further evaluation and management.

Before using Bharglob 16.5% Injection, it is essential to inform your healthcare provider if you have any blood clotting issues or have recently undergone or plan to receive vaccinations. The safety of this medication during pregnancy and breastfeeding is unknown, so seeking advice from a doctor is advised. Bharglob 16.5% Injection is part of the 'immunising agents' medication class and is primarily used to address immunoglobulin deficiency conditions and various inflammatory disorders affecting both early-onset and later-developed immunodeficiencies. It helps in replacing deficient antibodies vital for fighting infections and inflammation, working similarly to natural immunoglobulins present in the body.

Administration of Bharglob 16.5% Injection should only be performed by trained healthcare professionals to minimize risks. Possible side effects include swelling or hardening at the injection site, headaches, pain in various body parts, fever, and flu-like symptoms. Inform your doctor if these side effects persist or worsen over time.

Individuals allergic to any components of Bharglob 16.5% Injection or with blood clotting disorders should avoid using this medication. Caution is recommended in cases of immunoglobulin A deficiency, and it may be safely used by children, pregnant women, and breastfeeding mothers. Elderly individuals should also use Bharglob 16.5% Injection cautiously, as well as avoiding activities requiring alertness if experiencing dizziness as a possible side effect.